Label: ASPERCREME LIDOCAINE WITH ROSEMARY AND MINT- lidocaine hydrochloride cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated January 10, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Aspercreme Lidocaine with Rosemary & Mint

    Drug Facts

  • Active ingredient

    Lidocaine HCl 4%

  • Purpose

    Topical anesthetic

  • Use

    for the temporary relief of pain

  • Warnings

    For external use only

    Do not use

    • in large quantities
    • on wounds or on irritated or damaged skin
    • with a heating pad

    When using this product

    • use only as directed
    • do not bandage tightly
    • avoid contact with eyes and mucous membranes
    • do not expose the area to local heat or to direct sunlight

    Stop use and ask a doctor if

    • condition worsens or symptoms persist for more than 7 days
    • symptoms clear up and occur again within a few days
    • redness is present or excessive skin irritation occurs
    • you experience severe burning pain, swelling, or blistering where the product was applied

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • adults and children 12 years of age and older:
      • apply a thin layer to affected area every 6 to 8 hours, not more than 3 to 4 times daily
      • massage until thoroughly absorbed into skin
      • wash hands thoroughly with soap and water after each use
    • children under 12 years of age: ask a doctor
  • Inactive ingredients

    water, cetearyl alcohol, alcohol denat., ceteth-20 phosphate, dimethicone, caprylyl methicone, dicetyl phosphate, C30-45 alkyl cetearyl dimethicone crosspolymer, triethyl citrate, glycerl stearate, potassium hydroxide, aloe barbadensis leaf juice, hydroxyacetophenone, fragrance, acrylates/C10-30 alkyl acrylate crossploymer, ethylhexylglycerin, panthenol, tocopheryl acetate, magnesium ascorbyl phosphate

    Child-resistant packaging. Close cap tightly after use.

  • Principal Display Panel

    NEW!
    MAX STRENGTH
    Aspercreme®
    WITH 4% LIDOCAINE
    PAIN RELIEF CREAM
    NUMBS
    AWAY PAIN
    #1
    LIDOCAIN
    BRAND*
    FAST ACTING
    TARGETS NERVES
    FRESH
    ROSEMARY MINT
    SCENT
    With
    ROSEMARY
    & MINT
    Essential Oils
    *Among OTC topical analgesics.
    NET WT 1.75 OZ (49.6 g)

    Principal Display Panel NEW! MAX STRENGTH Aspercreme® WITH 4% LIDOCAINE PAIN RELIEF CREAM NUMBS AWAY PAIN #1 LIDOCAIN BRAND* FAST ACTING TARGETS NERVES FRESH ROSEMARY MINT SCENT With ROSEMARY & MINT Essential Oils *Among OTC topical analgesics. NET WT 1.75 OZ (49.6 g)

  • INGREDIENTS AND APPEARANCE
    ASPERCREME LIDOCAINE WITH ROSEMARY AND MINT 
    lidocaine hydrochloride cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0565
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    ALCOHOL (UNII: 3K9958V90M)  
    CETETH-20 PHOSPHATE (UNII: 921FTA1500)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL)  
    DIHEXADECYL PHOSPHATE (UNII: 2V6E5WN99N)  
    C30-45 ALKYL CETEARYL DIMETHICONE CROSSPOLYMER (UNII: 4ZK9VP326R)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
    CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:41167-0565-01 in 1 CARTON01/15/2024
    149.6 g in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01701/15/2024
    Labeler - Chattem, Inc. (003336013)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!